It is a common opinion that nitrate therapy may have a harmful effect
on cardiac output in patients with congestive heart failure when left
ventricular filling presssure is markedly reduced. In this study, we e
valuated, using hemodynamic monitoring with Swan-Ganz catheterization,
the effects on cardiac output and filling pressures of high-dose intr
avenous nitroglycerin in 8 patients with dilated cardiomyopathy and se
vere heart failure. At maximal doses of nitroglycerin utilized (350 +/
- 220 mu g/m, range 100-800), a significant reduction in right atrial
pressure (from 4 +/- 3.5 to -1 +/- 4 mm Hg, p < 0.001) and pulmonary c
apillary wedge pressure (from 16 +/- 5 to 7 +/- 3 mm Hg, p < 0.001) wa
s observed. Furthermore, we found neither a significant reduction in s
ystemic vascular resistances (from 1,500 +/- 329 to 1,320 +/- 330 dyne
s/s/cm(-5)) nor changes in heart rate or blood pressure. Finally, stro
ke volume and cardiac index increased slightly although not significan
tly (from 62 +/- 18 to 70 +/- 16 ml and from 2.3 +/- 0.45 to 2.65 +/-
0.4 l/m/m(2)). The preservation of stroke volume despite a marked redu
ction in left ventricular filling pressure can be explained by a reduc
tion in pericardial constraint and of mitral regurgitation induced by
nitroglycerin. The clinical implications of these hemodynamic results
are discussed with emphasis on the short- and long-term use of nitrate
s in congestive heart failure.